Short-term effects on bone turnover markers of a single high dose of oral vitamin D 3

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 4, 2012, Pages

  Rossini, Maurizio ^a   Gatti, Davide ^a   Viapiana, Ombretta ^a   Fracassi, Elena ^a   Idolazzi, Luca ^a   Zanoni, Silvia ^a   Adami, Silvano ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; AMINO TERMINAL TELOPEPTIDE; CALCITRIOL; CARBOXY TERMINAL TELOPEPTIDE; COLECALCIFEROL; OSTEOCALCIN; PARATHYROID HORMONE;

AGED; ARTICLE; BLOOD SAMPLING; BONE TURNOVER; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN CROSS LINKING; SINGLE DRUG DOSE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADMINISTRATION, ORAL; AGED; BIOLOGICAL MARKERS; BIOTRANSFORMATION; BONE AND BONES; BONE DENSITY CONSERVATION AGENTS; CALCIFEDIOL; CALCITRIOL; CHOLECALCIFEROL; COLLAGEN TYPE I; FEMALE; HUMANS; MALE; OSTEOCALCIN; OSTEOPOROSIS; PARATHYROID HORMONE; PEPTIDES; PHOSPHOPEPTIDES; PROCOLLAGEN; VITAMIN D DEFICIENCY;

EID: 84859542947     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-2448     Document Type: Article

References (22)

1. Holick MF 2006 High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81:353-373 (Pubitemid 43334631)
2. Lips P 2001 Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22:477-501 (Pubitemid 32762324)
3. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM 2011 Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96:1911-1930
4. Holick MF 2007 Vitamin D deficiency. N Engl J Med 357:266-281
5. Romagnoli E, Mascia ML, Cipriani C, Fassino V, Mazzei F, D'Erasmo E, Carnevale V, Scillitani A, Minisola S 2008 Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or vitamin D3 (vitamin D3) in the elderly. J Clin Endocrinol Metab 93:3015-3020
6. Bacon CJ, Gamble GD, Horne AM, Scott MA, Reid IR 2009 High-dose oral vitamin D3 supplementation in the elderly. Osteoporos Int 20:1407-1415
7. Bischoff-Ferrari HA 2007 How to select the doses of vitamin D in the management of osteoporosis. Osteoporos Int 18:401-407 (Pubitemid 46354929)
8. Trivedi DP, Doll R, Khaw KT 2003 Effect of four monthly oral vitamin D3 (Vitamin D3) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 326:469-475
9. Heikinheimo RJ, Inkovaara JA, Harju EJ, Haavisto MV, Kaarela RH, Kataja JM, Kokko AM, Kolho LA, Rajala SA 1992 Annual injection of vitamin D and fractures of aged bones. Calcif Tissue Int 51:105-110
10. Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, Nicholson GC 2010 Annual high-dose oral vitamin D and falls and fractures in older women. A randomized controlled trial. JAMA 303:1815-1822
11. Vasikaran S, Eastell R, Bruyère O, Foldes AJ, Garnero P, Griesmacher A, McClung M, Morris HA, Silverman S, Trenti T, Wahl DA, Cooper C, Kanis JA 2011 Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 22:391-420
12. Cipriani C, Romagnoli E, Scillitani A, Chiodini I, Clerico R, Carnevale V, Mascia ML, Battista C, Viti R, Pileri M, Eller-Vainicher C, Minisola S 2010 Effect of a single oral dose of 600,000 IU of Vitamin D3 on serum calciotropic hormones in young subjects with vitamin D deficiency: a prospective intervention study. J Clin Endocrinol Metab 95:4771-4777
13. Amrein K, Sourij H, Wagner G, Holl A, Pieber TR, Smolle KH, Stojakovic T, Schnedl C, Dobnig H 2011 Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study. Critical Care 15:R104
14. von Restorff C, Bischoff-Ferrari HA, Theiler R 2009 High-dose oral vitamin D3 supplementation in rheumatology patients with severe vitamin D3 deficiency. Bone 45:747-749
15. Adams JS, Clemens TL, Parrish JA, Holick MF 1982 Vitamin-D synthesis and metabolism after ultraviolet irradiation of normal and vitamin-D-deficient subjects. N Engl J Med 306:722-725 (Pubitemid 12183624)
16. Wu F, Staykova T, Horne A, Clearwater J, Ames R, Mason B, Orr-Walker B, Gamble G, Scott M, Reid I 2003 Efficacy of an oral, 10-day course of high-dose calciferol in correcting vitamin D deficiency. N Z Med J 116:U536
17. Hekkarinen T, Valimaki VV, Aaarum S, Turpeinen U, Hamalainen E, Loyttyniemi E, Valimaki MJ 2010 The same annual dose of 292000 IU of vitamin D3 (cholecalciferol) on either daily or four monthly basis for elderly women: 1-year comparative study of the effects on serum 25(OH)D3 concentrations and renal function. Clin Endocrinol (Oxf) 72:455-461
18. Giusti A, Barone A, Pioli G, Girasole G, Razzano M, Pizzonia M, Pedrazzoni M, Palummeri E, Bianchi G 2010 Heterogeneity in serum 25-hydroxy-vitamin D response to Vitamin D3 in elderly women with secondary hyperparathyroidism and vitamin D deficiency. J Am Geriatr Soc 58:1489-1495
19. Plum LA, DeLuca HF 2010 Vitamin D, disease and therapeutic opportunities. Nat Rev Drug Discov 9:941-955
20. Aubin JE, Bonnelye E 2000 Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption. Osteoporos Int 11:905-913 (Pubitemid 32044070)
21. Demay MB, Gerardi JM, DeLuca HF, Kronenberg HM 1990 DNA sequences in the rat osteocalcin gene that bind the 1,25-dihydroxyvitamin D3 receptor and confer responsiveness to 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 87:369-373
22. Adami S, Kanis JA 1995 Assessment of involutional bone loss: methodological and conceptual problems. J Bone Miner Res 10:511-517